Patch pumps are the convergence of several technologies into a single drug delivery device package. In doing so, this class of devices overcomes a number of shortcomings and limitations, while simplifying the drug administration event at the patient interface. The current generation of patch pumps focuses on insulin delivery, but a number of devices have been designed and are being developed to be - within the limits of drug pharmacology - essentially API agnostic. This report analyzes important therapeutic segments and examines key regulatory, economic and competitive factors that represent potential barriers to commercial success.
A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.
Browse more Drug Delivery Devices Market Research Reports